Labeler
E.R. Squibb & Sons, L.L.C. NDC Codes
E.R. Squibb & Sons, L.L.C. lists 51 finished drug products in the FDA NDC Directory under NDC labeler code 0003.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Sprycel, Cobenfy, Opdivo, Orencia, Eliquis, Reyataz, Baraclude, Zenbexus, Opdivo Qvantig, Augtyro, ELIQUIS 30-Day Starter Pack, Empliciti, Yervoy, Azactam, Eliquis Sprinkle
- Active ingredients
- Nivolumab, Dasatinib, Apixaban, Atazanavir sulfate, Abatacept, Xanomeline, Trospium chloride, Triamcinolone acetonide, Entecavir, Iberdomide hydrochloride, Hyaluronidase (Human recombinant), Repotrectinib
- NDC labeler codes
- 0003
- Strengths
- Nivolumab 10 mg/mL; Nivolumab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL; Trospium chloride 20 mg/1; Atazanavir sulfate 300 mg/1; Ipilimumab 5 mg/mL; Iberdomide hydrochloride .75 mg/1; Iberdomide hydrochloride 1 mg/1; Apixaban .15 mg/1; Apixaban .5 mg/1; Repotrectinib 160 mg/1; Xanomeline 50 mg/1; Xanomeline 125 mg/1; Trospium chloride 30 mg/1; Xanomeline 100 mg/1; Repotrectinib 40 mg/1; Deucravacitinib 6 mg/1; Nivolumab 12 mg/mL; Relatlimab 4 mg/mL; Triamcinolone acetonide 80 mg/mL
- Dosage forms
- Injection, Tablet, Capsule, Injection, Solution, Tablet, Film coated, Kit, Injection, Powder, Lyophilized, For solution, Capsule, Coated pellets, Injection, Suspension, Injection, Powder, For solution, Solution, Capsule, Gelatin coated, Tablet, For suspension, Powder
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Intra-articular, Intralesional, Topical
- Drug classes (FDA established)
- Kinase Inhibitor, Programmed Death Receptor-1 Blocking Antibody, Factor Xa Inhibitor, Corticosteroid, Protease Inhibitor, Selective T Cell Costimulation Modulator, Cholinergic Muscarinic Agonist, Cholinergic Muscarinic Antagonist, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Endoglycosidase, SLAMF7-directed Immunostimulatory Antibody, CTLA-4-directed Blocking Antibody, Monobactam Antibacterial, Tyrosine Kinase 2 Inhibitor, Lymphocyte Activation Gene-3 Blocker, Cytochrome P450 3A Inhibitor, Selective T Cell Costimulation Blocker
- HCPCS / J-code
- J9299 — Injection, nivolumab, 1 mg
- Package NDCs
- 73
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Reyatazatazanavir | Atazanavir sulfate 200 mg/1 | Capsule, Gelatin coatedOral | 0003-3631 | 00003-3631-12 | — |
E.R. Squibb & Sons, L.L.C.: common questions
- What is E.R. Squibb & Sons, L.L.C.'s NDC labeler code?
- 0003. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for E.R. Squibb & Sons, L.L.C.?
- Med-Code's HCPCS directory matches J9299 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.